Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate

Background and Objectives: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many s...

Full description

Bibliographic Details
Main Authors: Ava Behrouzi, Reza Arabi Mianroodi, Parviz Afrough, Ahmad Ayadi, Amirarsalan Serajian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-10-01
Series:Iranian Journal of Microbiology
Subjects:
Online Access:https://ijm.tums.ac.ir/index.php/ijm/article/view/2049
_version_ 1818384104756871168
author Ava Behrouzi
Reza Arabi Mianroodi
Parviz Afrough
Ahmad Ayadi
Amirarsalan Serajian
author_facet Ava Behrouzi
Reza Arabi Mianroodi
Parviz Afrough
Ahmad Ayadi
Amirarsalan Serajian
author_sort Ava Behrouzi
collection DOAJ
description Background and Objectives: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many studies have been conducted on the use of OMV as a vaccine against NTHi. The purpose of this study is to achieve an immunogenic vaccine against NTHi. Materials and Methods: In this study, standard OMV Haemophilus (ATCC49766) with adjuncts CpG and MPLA was used and after infusion into BALB/c mice, the levels of antibodies and cytokines were measured on serum of immunized mice. Results: The results showed that total IgG antibody and IgG1 and IgG2a isotypes in OMV immunized mice with mixture of CpG-MPLA adjuvant had a significant increase. Also, the results of cytokines (IL-10, IL-4 and IFN-γ) showed that IL-4 had the highest rate. Conclusion: These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.
first_indexed 2024-12-14T03:16:58Z
format Article
id doaj.art-05d7fe3888b149b8b449b777643588d5
institution Directory Open Access Journal
issn 2008-3289
2008-4447
language English
last_indexed 2024-12-14T03:16:58Z
publishDate 2020-10-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Microbiology
spelling doaj.art-05d7fe3888b149b8b449b777643588d52022-12-21T23:19:06ZengTehran University of Medical SciencesIranian Journal of Microbiology2008-32892008-44472020-10-0112510.18502/ijm.v12i5.4602Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidateAva Behrouzi0Reza Arabi Mianroodi1Parviz Afrough2Ahmad Ayadi3Amirarsalan Serajian4Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, IranDepartment of R&D, Research and Production Complex, Pasteur Institute of Iran, Tehran, IranDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, IranDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, IranDepartment of Health Education, ACECR, Khuzestan, Ahvaz, IranBackground and Objectives: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many studies have been conducted on the use of OMV as a vaccine against NTHi. The purpose of this study is to achieve an immunogenic vaccine against NTHi. Materials and Methods: In this study, standard OMV Haemophilus (ATCC49766) with adjuncts CpG and MPLA was used and after infusion into BALB/c mice, the levels of antibodies and cytokines were measured on serum of immunized mice. Results: The results showed that total IgG antibody and IgG1 and IgG2a isotypes in OMV immunized mice with mixture of CpG-MPLA adjuvant had a significant increase. Also, the results of cytokines (IL-10, IL-4 and IFN-γ) showed that IL-4 had the highest rate. Conclusion: These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.https://ijm.tums.ac.ir/index.php/ijm/article/view/2049Non typeable Haemophilus influenza;Outer membrane vesicle;Vaccine
spellingShingle Ava Behrouzi
Reza Arabi Mianroodi
Parviz Afrough
Ahmad Ayadi
Amirarsalan Serajian
Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
Iranian Journal of Microbiology
Non typeable Haemophilus influenza;
Outer membrane vesicle;
Vaccine
title Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_full Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_fullStr Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_full_unstemmed Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_short Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_sort evaluation of immunological responses against outer membrane vesicles omv of nontypeable haemophilus influenzae using mpla cpg adjuvant as a vaccine candidate
topic Non typeable Haemophilus influenza;
Outer membrane vesicle;
Vaccine
url https://ijm.tums.ac.ir/index.php/ijm/article/view/2049
work_keys_str_mv AT avabehrouzi evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT rezaarabimianroodi evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT parvizafrough evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT ahmadayadi evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT amirarsalanserajian evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate